The Use of Upconversion Nanoparticles in Prostate Cancer Photodynamic Therapy

Overview

Journal Life (Basel)

Specialty Biology

Date 2021 Apr 30

PMID 33921611

Citations 11

Authors

Michal Osuchowski

Filip Osuchowski

Wojciech Latos

Aleksandra Kawczyk-Krupka

Affiliations

Soon will be listed here.

Abstract

Photodynamic Therapy (PDT) is a cancer treatment that uses light, a photosensitizer, and oxygen to destroy tumors. This article is a review of approaches to the treatment of prostate cancer applying upconversion nanoparticles (UCNPs). UCNPs have become a phenomenon that are rapidly gaining recognition in medicine. They have proven to be highly selective and specific and present a powerful tool in the diagnosis and treatment of prostate cancer. Prostate cancer is a huge health problem in Western countries. Its early detection can significantly improve patients' prognosis, but currently used diagnostic methods leave much to be desired. Recently developed methodologies regarding UCNP research between the years 2021 and 2014 for prostate cancer PDT will also be discussed. Current limitations in PDT include tissue irradiation with visible wavelengths that have a short tissue penetration depth. PDT with the objectives to synthesize UCNPs composed of a lanthanide core with a coating of adsorbed dye that will generate fluorescence after excitation with near-infrared light to illuminate deep tissue is a subject of intense research in prostate cancer.

Citing Articles

Advances in smart nanotechnology-supported photodynamic therapy for cancer.

Li G, Wang C, Jin B, Sun T, Sun K, Wang S Cell Death Discov. 2024; 10(1):466.

PMID: 39528439 PMC: 11554787. DOI: 10.1038/s41420-024-02236-4.

Zinc Oxide Nanoparticles Blunt Potassium-Bromate-Induced Renal Toxicity by Reinforcing the Redox System.

Alhazza I, Hassan I, Ebaid H, Al-Tamimi J, Hasan Z Molecules. 2023; 28(13).

PMID: 37446744 PMC: 10343659. DOI: 10.3390/molecules28135084.

Photoluminescent Scaffolds Based on Natural and Synthetic Biodegradable Polymers for Bioimaging and Tissue Engineering.

Trifanova E, Babayeva G, Khvorostina M, Atanova A, Nikolaeva M, Sochilina A Life (Basel). 2023; 13(4).

PMID: 37109400 PMC: 10141962. DOI: 10.3390/life13040870.

Eosin Y-Functionalized Upconverting Nanoparticles: Nanophotosensitizers and Deep Tissue Bioimaging Agents for Simultaneous Therapeutic and Diagnostic Applications.

Lopez-Pena G, Simon-Fuente S, Ortgies D, Moline M, Martin Rodriguez E, Sanz-Rodriguez F Cancers (Basel). 2023; 15(1).

PMID: 36612098 PMC: 9817929. DOI: 10.3390/cancers15010102.

Insights on the Dynamic Innovative Tumor Targeted-Nanoparticles-Based Drug Delivery Systems Activation Techniques.

Hamdy N, Eskander G, Basalious E Int J Nanomedicine. 2022; 17:6131-6155.

PMID: 36514378 PMC: 9741821. DOI: 10.2147/IJN.S386037.

References

Lu J, Chen Y, Liu D, Ren W, Lu Y, Shi Y . One-Step Protein Conjugation to Upconversion Nanoparticles. Anal Chem. 2015; 87(20):10406-13. DOI: 10.1021/acs.analchem.5b02523. View

Hoshyar N, Gray S, Han H, Bao G . The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine (Lond). 2016; 11(6):673-92. PMC: 5561790. DOI: 10.2217/nnm.16.5. View

Sun Y, Feng W, Yang P, Huang C, Li F . The biosafety of lanthanide upconversion nanomaterials. Chem Soc Rev. 2014; 44(6):1509-25. DOI: 10.1039/c4cs00175c. View

Chen Y, DAmario C, Gee A, Duong H, Shimoni O, Valenzuela S . Dispersion stability and biocompatibility of four ligand-exchanged NaYF: Yb, Er upconversion nanoparticles. Acta Biomater. 2019; 102:384-393. DOI: 10.1016/j.actbio.2019.11.048. View

Morrison D, Aitken J, de Jonge M, Ioppolo J, Harris H, Rendina L . High mitochondrial accumulation of new gadolinium(III) agents within tumour cells. Chem Commun (Camb). 2013; 50(18):2252-4. DOI: 10.1039/c3cc46903d. View

Michalet X, Pinaud F, Bentolila L, Tsay J, Doose S, Li J . Quantum dots for live cells, in vivo imaging, and diagnostics. Science. 2005; 307(5709):538-44. PMC: 1201471. DOI: 10.1126/science.1104274. View

Li X, Wei L, Pan L, Yi Z, Wang X, Ye Z . Homogeneous Immunosorbent Assay Based on Single-Particle Enumeration Using Upconversion Nanoparticles for the Sensitive Detection of Cancer Biomarkers. Anal Chem. 2018; 90(7):4807-4814. DOI: 10.1021/acs.analchem.8b00251. View

Jung B, Zhu Y, Santiago J . Detection of 100 aM fluorophores using a high-sensitivity on-chip CE system and transient isotachophoresis. Anal Chem. 2006; 79(1):345-9. DOI: 10.1021/ac060949p. View

Collins F, Varmus H . A new initiative on precision medicine. N Engl J Med. 2015; 372(9):793-5. PMC: 5101938. DOI: 10.1056/NEJMp1500523. View

10.

Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T . EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. Eur Urol. 2016; 71(4):630-642. DOI: 10.1016/j.eururo.2016.08.002. View

11.

Czaderny K . High prostate cancer mortality in Poland. A spatial, temporal and structural analysis. Przegl Epidemiol. 2018; 72(2):235-246. View

12.

Farka Z, Mickert M, Hlavacek A, Skladal P, Gorris H . Single Molecule Upconversion-Linked Immunosorbent Assay with Extended Dynamic Range for the Sensitive Detection of Diagnostic Biomarkers. Anal Chem. 2017; 89(21):11825-11830. DOI: 10.1021/acs.analchem.7b03542. View

13.

Kong M, Gu Y, Liu Y, Shi Y, Wu N, Feng W . Luminescence Lifetime-Based In Vivo Detection with Responsive Rare Earth-Dye Nanocomposite. Small. 2019; 15(46):e1904487. DOI: 10.1002/smll.201904487. View

14.

Lu Y, Lu J, Zhao J, Cusido J, Raymo F, Yuan J . On-the-fly decoding luminescence lifetimes in the microsecond region for lanthanide-encoded suspension arrays. Nat Commun. 2014; 5:3741. PMC: 4024748. DOI: 10.1038/ncomms4741. View

15.

Xia A, Chen M, Gao Y, Wu D, Feng W, Li F . Gd3+ complex-modified NaLuF4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance. Biomaterials. 2012; 33(21):5394-405. DOI: 10.1016/j.biomaterials.2012.04.025. View

16.

Gnach A, Lipinski T, Bednarkiewicz A, Rybka J, Capobianco J . Upconverting nanoparticles: assessing the toxicity. Chem Soc Rev. 2014; 44(6):1561-84. DOI: 10.1039/c4cs00177j. View

17.

Zou X, Yao M, Ma L, Hossu M, Han X, Juzenas P . X-ray-induced nanoparticle-based photodynamic therapy of cancer. Nanomedicine (Lond). 2014; 9(15):2339-51. DOI: 10.2217/nnm.13.198. View

18.

Guryev E, Volodina N, Shilyagina N, Gudkov S, Balalaeva I, Volovetskiy A . Radioactive (Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer. Proc Natl Acad Sci U S A. 2018; 115(39):9690-9695. PMC: 6166851. DOI: 10.1073/pnas.1809258115. View

19.

Cho W, Duffin R, Howie S, Scotton C, Wallace W, MacNee W . Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol. 2011; 8:27. PMC: 3179432. DOI: 10.1186/1743-8977-8-27. View

20.

Lei Q, Zhao L, Ye S, Sun Y, Xie F, Zhang H . Rapid and quantitative detection of urinary Cyfra21-1 using fluorescent nanosphere-based immunochromatographic test strip for diagnosis and prognostic monitoring of bladder cancer. Artif Cells Nanomed Biotechnol. 2019; 47(1):4266-4272. DOI: 10.1080/21691401.2019.1687491. View